Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4)

Michele M. Mumaw, Maria De La Fuente, Amal Arachiche, James K Wahl, Marvin T. Nieman

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background Protease activated receptor 4 (PAR4) is a G protein coupled receptor (GPCR) which is activated by proteolytic cleavage of its N-terminal exodomain. This generates a tethered ligand that activates the receptor and triggers downstream signaling events. With the current focus in the development of anti-platelet therapies shifted towards PARs, new reagents are needed for expanding the field's knowledge on PAR4. Currently, there are no PAR4 reagents which are able to detect activation of the receptor. Methods Monoclonal PAR4 antibodies were purified from hybridomas producing antibody that were generated by fusing splenocytes with NS-1 cells. Immunoblotting, immunofluorescence, and flow cytometry were utilized to detect the epitope for each antibody and to evaluate the interaction of the antibodies with cells. Results Here, we report the successful generation of three monoclonal antibodies to the N-terminal extracellular domain of PAR4: 14H6, 5 F10, and 2D6. We mapped the epitope on PAR4 of 14H6, 5 F10, and 2D6 antibodies to residues (48-53), (41-47), and (73-78), respectively. Two of the antibodies (14H6 and 5 F10) interacted close to the thrombin cleavage and were sensitive to α-thrombin cleavage of PAR4. In addition, 5 F10 was able to partially inhibit the cleavage of PAR4 expressed in HEK293 cells by α-thrombin. Conclusions These new antibodies provide a means to monitor endogenous PAR4 expression and activation by proteases on cells.

Original languageEnglish (US)
Pages (from-to)1165-1171
Number of pages7
JournalThrombosis Research
Volume135
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Monoclonal Antibodies
Antibodies
Thrombin
Epitopes
protease-activated receptor 4
HEK293 Cells
Hybridomas
G-Protein-Coupled Receptors
Immunoblotting
Fluorescent Antibody Technique
Flow Cytometry
Peptide Hydrolases
Blood Platelets
Ligands

Keywords

  • G-protein coupled receptor
  • Monoclonal antibody
  • Platelets
  • Protease activated receptor 4
  • Thrombin receptor

ASJC Scopus subject areas

  • Hematology

Cite this

Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4). / Mumaw, Michele M.; De La Fuente, Maria; Arachiche, Amal; Wahl, James K; Nieman, Marvin T.

In: Thrombosis Research, Vol. 135, No. 6, 01.06.2015, p. 1165-1171.

Research output: Contribution to journalArticle

Mumaw, Michele M. ; De La Fuente, Maria ; Arachiche, Amal ; Wahl, James K ; Nieman, Marvin T. / Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4). In: Thrombosis Research. 2015 ; Vol. 135, No. 6. pp. 1165-1171.
@article{1e91050c20c04684a584325ba3646c91,
title = "Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4)",
abstract = "Background Protease activated receptor 4 (PAR4) is a G protein coupled receptor (GPCR) which is activated by proteolytic cleavage of its N-terminal exodomain. This generates a tethered ligand that activates the receptor and triggers downstream signaling events. With the current focus in the development of anti-platelet therapies shifted towards PARs, new reagents are needed for expanding the field's knowledge on PAR4. Currently, there are no PAR4 reagents which are able to detect activation of the receptor. Methods Monoclonal PAR4 antibodies were purified from hybridomas producing antibody that were generated by fusing splenocytes with NS-1 cells. Immunoblotting, immunofluorescence, and flow cytometry were utilized to detect the epitope for each antibody and to evaluate the interaction of the antibodies with cells. Results Here, we report the successful generation of three monoclonal antibodies to the N-terminal extracellular domain of PAR4: 14H6, 5 F10, and 2D6. We mapped the epitope on PAR4 of 14H6, 5 F10, and 2D6 antibodies to residues (48-53), (41-47), and (73-78), respectively. Two of the antibodies (14H6 and 5 F10) interacted close to the thrombin cleavage and were sensitive to α-thrombin cleavage of PAR4. In addition, 5 F10 was able to partially inhibit the cleavage of PAR4 expressed in HEK293 cells by α-thrombin. Conclusions These new antibodies provide a means to monitor endogenous PAR4 expression and activation by proteases on cells.",
keywords = "G-protein coupled receptor, Monoclonal antibody, Platelets, Protease activated receptor 4, Thrombin receptor",
author = "Mumaw, {Michele M.} and {De La Fuente}, Maria and Amal Arachiche and Wahl, {James K} and Nieman, {Marvin T.}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.thromres.2015.03.027",
language = "English (US)",
volume = "135",
pages = "1165--1171",
journal = "Thrombosis Research",
issn = "0049-3848",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Development and characterization of monoclonal antibodies against Protease Activated Receptor 4 (PAR4)

AU - Mumaw, Michele M.

AU - De La Fuente, Maria

AU - Arachiche, Amal

AU - Wahl, James K

AU - Nieman, Marvin T.

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Background Protease activated receptor 4 (PAR4) is a G protein coupled receptor (GPCR) which is activated by proteolytic cleavage of its N-terminal exodomain. This generates a tethered ligand that activates the receptor and triggers downstream signaling events. With the current focus in the development of anti-platelet therapies shifted towards PARs, new reagents are needed for expanding the field's knowledge on PAR4. Currently, there are no PAR4 reagents which are able to detect activation of the receptor. Methods Monoclonal PAR4 antibodies were purified from hybridomas producing antibody that were generated by fusing splenocytes with NS-1 cells. Immunoblotting, immunofluorescence, and flow cytometry were utilized to detect the epitope for each antibody and to evaluate the interaction of the antibodies with cells. Results Here, we report the successful generation of three monoclonal antibodies to the N-terminal extracellular domain of PAR4: 14H6, 5 F10, and 2D6. We mapped the epitope on PAR4 of 14H6, 5 F10, and 2D6 antibodies to residues (48-53), (41-47), and (73-78), respectively. Two of the antibodies (14H6 and 5 F10) interacted close to the thrombin cleavage and were sensitive to α-thrombin cleavage of PAR4. In addition, 5 F10 was able to partially inhibit the cleavage of PAR4 expressed in HEK293 cells by α-thrombin. Conclusions These new antibodies provide a means to monitor endogenous PAR4 expression and activation by proteases on cells.

AB - Background Protease activated receptor 4 (PAR4) is a G protein coupled receptor (GPCR) which is activated by proteolytic cleavage of its N-terminal exodomain. This generates a tethered ligand that activates the receptor and triggers downstream signaling events. With the current focus in the development of anti-platelet therapies shifted towards PARs, new reagents are needed for expanding the field's knowledge on PAR4. Currently, there are no PAR4 reagents which are able to detect activation of the receptor. Methods Monoclonal PAR4 antibodies were purified from hybridomas producing antibody that were generated by fusing splenocytes with NS-1 cells. Immunoblotting, immunofluorescence, and flow cytometry were utilized to detect the epitope for each antibody and to evaluate the interaction of the antibodies with cells. Results Here, we report the successful generation of three monoclonal antibodies to the N-terminal extracellular domain of PAR4: 14H6, 5 F10, and 2D6. We mapped the epitope on PAR4 of 14H6, 5 F10, and 2D6 antibodies to residues (48-53), (41-47), and (73-78), respectively. Two of the antibodies (14H6 and 5 F10) interacted close to the thrombin cleavage and were sensitive to α-thrombin cleavage of PAR4. In addition, 5 F10 was able to partially inhibit the cleavage of PAR4 expressed in HEK293 cells by α-thrombin. Conclusions These new antibodies provide a means to monitor endogenous PAR4 expression and activation by proteases on cells.

KW - G-protein coupled receptor

KW - Monoclonal antibody

KW - Platelets

KW - Protease activated receptor 4

KW - Thrombin receptor

UR - http://www.scopus.com/inward/record.url?scp=84929517763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929517763&partnerID=8YFLogxK

U2 - 10.1016/j.thromres.2015.03.027

DO - 10.1016/j.thromres.2015.03.027

M3 - Article

VL - 135

SP - 1165

EP - 1171

JO - Thrombosis Research

JF - Thrombosis Research

SN - 0049-3848

IS - 6

ER -